Beta-blocker use and mortality among patients with systolic heart failure and pacemaker rhythm.
Andrew S PerryAldo P MaggioniLuigi TavazziWayne C LevyPublished in: ESC heart failure (2023)
Beta-blocker therapy is associated with improved survival among patients with heart failure and a pacemaker rhythm on ECG. Further studies are necessary to analyse differences between atrial and ventricular pacemakers.
Keyphrases
- heart failure
- atrial fibrillation
- left ventricular
- heart rate
- catheter ablation
- left atrial
- blood pressure
- angiotensin converting enzyme
- vena cava
- acute heart failure
- cardiac resynchronization therapy
- heart rate variability
- cardiovascular events
- mitral valve
- risk factors
- angiotensin ii
- cardiovascular disease
- type diabetes
- mesenchymal stem cells
- coronary artery disease
- bone marrow